全文获取类型
收费全文 | 14020篇 |
免费 | 2561篇 |
国内免费 | 86篇 |
专业分类
耳鼻咽喉 | 300篇 |
儿科学 | 3336篇 |
妇产科学 | 118篇 |
基础医学 | 643篇 |
口腔科学 | 295篇 |
临床医学 | 1627篇 |
内科学 | 1311篇 |
皮肤病学 | 224篇 |
神经病学 | 405篇 |
特种医学 | 281篇 |
外国民族医学 | 2篇 |
外科学 | 1897篇 |
综合类 | 473篇 |
一般理论 | 3篇 |
预防医学 | 590篇 |
眼科学 | 262篇 |
药学 | 708篇 |
32篇 | |
中国医学 | 193篇 |
肿瘤学 | 3967篇 |
出版年
2024年 | 11篇 |
2023年 | 688篇 |
2022年 | 308篇 |
2021年 | 806篇 |
2020年 | 1172篇 |
2019年 | 1276篇 |
2018年 | 1193篇 |
2017年 | 1050篇 |
2016年 | 797篇 |
2015年 | 819篇 |
2014年 | 1053篇 |
2013年 | 1476篇 |
2012年 | 790篇 |
2011年 | 719篇 |
2010年 | 622篇 |
2009年 | 625篇 |
2008年 | 572篇 |
2007年 | 496篇 |
2006年 | 408篇 |
2005年 | 325篇 |
2004年 | 192篇 |
2003年 | 175篇 |
2002年 | 128篇 |
2001年 | 123篇 |
2000年 | 97篇 |
1999年 | 86篇 |
1998年 | 82篇 |
1997年 | 82篇 |
1996年 | 54篇 |
1995年 | 55篇 |
1994年 | 49篇 |
1993年 | 43篇 |
1992年 | 44篇 |
1991年 | 38篇 |
1990年 | 22篇 |
1989年 | 28篇 |
1988年 | 25篇 |
1987年 | 14篇 |
1986年 | 11篇 |
1985年 | 23篇 |
1984年 | 28篇 |
1983年 | 16篇 |
1982年 | 14篇 |
1981年 | 7篇 |
1980年 | 14篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
熊磊教授以理脾为本,将治痰贯穿始终。根据小儿脾常不足、肾常虚、肝常有余的生理特点,癫痫发作期治疗主以涤痰开窍,辅以理气健脾,同时配合活血化瘀通窍与平肝息风潜阳。主要选方为柴芍温胆汤、天麻钩藤饮、桃红四物汤加减;缓解期则以补肾养肝为主,兼以健脾化痰,主要选方为杞菊地黄丸合定痫丸加减,取得较好临床疗效。 相似文献
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
Qing-Yang Que Lin-Cheng Zhang Jia-Qi Bao Sun-Bin Ling Xiao Xu 《World journal of gastrointestinal surgery》2022,14(5):397-408
Over the last 40 years, the incidence and prevalence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have continued to increase. Compared to other epithelial neoplasms in the same organ, GEP-NENs exhibit indolent biological behavior, resulting in more chances to undergo surgery. However, the role of surgery in high-grade or advanced GEP-NENs is still controversial. Surgery is associated with survival improvement of well-differentiated high-grade GEP-NENs, whereas poorly differentiated GEP-NENs that may benefit from resection require careful selection based on Ki67 and other tissue bio markers. Additionally, surgery also plays an important role in locally advanced and metastatic disease. For locally advanced GEP-NENs, isolated major vascular involvement is no longer an absolute contraindication. In the setting of metastatic GEP-NENs, radical intended surgery is recommended for patients with low-grade and resectable metastases. For unresectable metastatic disease, a variety of surgical approaches, including cytoreduction of liver metastasis, liver transplantation, and surgery after neoadjuvant treatment, show survival benefits. Primary tumor resection in GEP-NENs with unresectable metastatic disease is associated with symptom control, prolonged survival, and improved sensitivity toward systemic therapies. Although there is no established neoadjuvant or adjuvant strategy, increasing attention has been given to this emerging research area. Some studies have reported that neoadjuvant therapy effectively reduces tumor burden, improves the effectiveness of subsequent surgery, and decreases surgical complications. 相似文献
4.
目的研究风险管理在儿科急诊护理工作中的应用。方法选取2021年10月至12月间来我科室就诊的100例患儿作为研究对象,将其分为研究组、对照组两组,每组各50例患儿。运用常规护理模式护理对照组患儿,运用风险管理模式,为研究组患儿给予护理干预,分析二组发生不良护理事故的情况并统计护理满意度。结果研究期间,研究组不良护理事件发生率为2.0%,对照组不良护理事件发生率为12.0%;研究组对护理工作的满意度为98.0%,对照组对护理工作的满意度为84.0%,P<0.05,组间差异具统计学意义。结论将风险管理应用于儿科急诊护理工作,可降低不良事件发生几率,保障患儿安全,具有推广应用价值。 相似文献
5.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
6.
7.
8.
9.
Aliyah Hussein Kiran Sran Imran Ali Janine Woellner Helen Wilcox Stephen D. Marks Helen Jones Chris Callaghan 《Pediatric transplantation》2020,24(4)
Transplant ureteric stent insertion reduces the incidence of MUCs, but it is not known whether routine PSRGU is needed to detect unmasked MUCs. This study evaluated whether routine PSRGU in the pRTR is a useful tool to identify MUCs before they become clinically apparent. A retrospective analysis was undertaken of the clinical outcomes following elective stent removal from pediatric kidney‐only transplant recipients at two London centers between 2012 and 2016. Our policy was to perform PSRGU either routinely or urgently if there were concerning symptoms or biochemical evidence of renal allograft dysfunction. Elective stent removal was performed in 86% (97 of 113 pRTR), and 75 (77%) of whom had routine PSRGU at a median (IQR) of 6 (2‐8) days after stent removal. There were changes to management in 3 (4%) of pRTR with PSRGU identifying no MUC. Nineteen patients (25%) had urgent PSRGU, most commonly due to renal allograft dysfunction, at a median (IQR) of 5.5 (2.7‐12.3) days after stent removal. Of these, two pRTR required ureteric intervention. For our current practice of removing transplant stents at 4‐6 weeks post‐transplantation, our study has found no evidence to support routine PSRGU after elective stent removal. 相似文献